RANGE: docetaxel with or without ramucirumab for metastatic urothelial carcinoma
10 Sep 2017
RANGE: docetaxel with or without ramucirumab for metastatic urothelial carcinoma
Long term efficacy of denosumab for giant cell bone tumours
Returning to work after cancer
STORM trial to identify genetic variability in metastatic breast cancer
The UNICANCER-NeoPAL study of letrozole and palbociclib in luminal cancer
STAMPEDE: Abiraterone acetate plus prednisolone or docetaxel
Problems with care: a patients perspective
Reduced work ability in cancer survivors
Problems with survivorship care in Europe
Underprovision and inequality of specialised cancer care
Regorafenib versus lomustine for relapsed glioblastoma
Reviewing LORELEI, mindACT and ExteNET trials in breast cancer